Insmed Inc. (INSM) Drops 5.35% on January 11

Equities Staff |

Insmed Inc. (INSM) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 5.35% to $15.22, a loss of $-0.86 per share. Starting at an opening price of $16.24 a share, the stock traded between $15.18 and $16.24 over the course of the trading day. Volume was 564,900 shares over 5,583 trades, against an average daily volume of 531,979 shares and a total float of 61.8 million.

The losses send Insmed Inc. down to a market cap of $940.65 million. In the last year, Insmed Inc. has traded between $28.66 and $13.93, and its 50-day SMA is currently $17.37 and 200-day SMA is $21.60.

Insmed Inc is a biopharmaceutical company engaged in developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. Its products candidates includes ARIKAYCE.

Insmed Inc. is based out of Bridgewater, NJ and has some 89 employees. Its CEO is William Lewis.

For a complete fundamental analysis analysis of Insmed Inc., check out’s Stock Valuation Analysis report for INSM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…